在生物医药领域,年销售额突破10亿美元的大品种,被形象地称为“重磅炸弹”(Blockbuster)药物。据悉,国产创新药又迎来一款重磅炸弹药物,即来自中国创新药企业传奇生物的CAR-T产品Carvykti(西达基奥仑赛注射液)。根据数据显示,西达基奥仑赛注射液2025年销售大增,全球销售金额达到18.87亿美元,与2024年同期收入9.63亿美元相比,增长95.95%。其中,2025年第四季度该...
Source Link在生物医药领域,年销售额突破10亿美元的大品种,被形象地称为“重磅炸弹”(Blockbuster)药物。据悉,国产创新药又迎来一款重磅炸弹药物,即来自中国创新药企业传奇生物的CAR-T产品Carvykti(西达基奥仑赛注射液)。根据数据显示,西达基奥仑赛注射液2025年销售大增,全球销售金额达到18.87亿美元,与2024年同期收入9.63亿美元相比,增长95.95%。其中,2025年第四季度该...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.